A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.
Lam Dennis S C, Chan Carmen K M, Mohamed Shaheeda, Lai Timothy Y Y, Li Kenneth K W, Li Patrick S H et al.
This study found higher doses of intravitreal triamcinolone (8mg vs 4mg) for diabetic macular edema resulted in significantly better visual acuity improvement, suggesting potential for more sustained benefit despite similar pressure risks.